This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Procter & Gamble (PG) Stock Moves -0.19%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $138.42 in the latest trading session, marking a -0.19% move from the prior day.
Should iShares Morningstar LargeCap Value ETF (JKF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKF
Procter & Gamble (PG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $136.55 in the latest trading session, marking a -0.71% move from the prior day.
5 Stocks to Benefit From Continued Weakening of US Dollar
by Payal Jalan
Solid international business places U.S.-based companies in an advantageous position to benefit from weakening U.S. dollar. Five such companies from different industries are AAPL, PG, MCD, CAT and GE.
Is Fidelity High Dividend ETF (FDVV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FDVV
Procter & Gamble (PG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $137.27, marking a +0.45% move from the previous day.
Why Procter & Gamble (PG) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
AptarGroup (ATR) Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Triggered by the pandemic, increasing demand for pharmaceutical products and sanitizers, liquid soaps and disinfectants featuring AptarGroup's (ATR) solutions is driving its shares.
Xerox (XRX) Names Xavier Heiss as Chief Financial Officer
by Zacks Equity Research
Heiss' huge work experience with Xerox (XRX) in the areas of finance, sales and general management is expected to be very useful for the company's ongoing transformation process.
Procter & Gamble (PG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $135.51 in the latest trading session, marking a -0.66% move from the prior day.
Procter & Gamble (PG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $137.47, marking a +0.09% move from the previous day.
5 Soaps & Cleaning Products Stocks Worth a Look Amid Coronavirus Woes
by Vidya Nair
The COVID-led rising demand for hygiene products is a boon for several soap and cleaning materials companies such as Procter & Gamble (PG), Unilever (UL), Colgate (CL), Clorox (CLX) and Church & Dwight (CHD), However, rising input costs are a concern.
The Zacks Analyst Blog Highlights: Microsoft, PG, TMUS, BA and GS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, PG, TMUS, BA and GS
Should iShares Morningstar LargeCap Value ETF (JKF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKF
Here's Why You Should Add Newell (NWL) to Your Portfolio Now
by Zacks Equity Research
Newell Brands (NWL) looks poised to gain from robust consumption patterns, higher demand for certain categories and a solid online show.
Top Analyst Reports for Microsoft, Procter & Gamble & T-Mobile
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), The Procter & Gamble Company (PG) and T-Mobile US (TMUS).
Why Procter & Gamble (PG) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
Is Fidelity High Dividend ETF (FDVV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FDVV
AptarGroup (ATR) Hits 52-Week High: What's Driving the Rally?
by Zacks Equity Research
Pandemic-induced demand for pharmaceutical products is likely to drive AptarGroup's (ATR) Pharma segment, while demand in personal care market and home care market will aid the Beauty + Home segment.
Here's Why You Should Hold On to AptarGroup (ATR) Stock Now
by Zacks Equity Research
Investors can retain AptarGroup (ATR) stock in their portfolio for the time being on upbeat prospects.
Why Is P&G (PG) Down 2.5% Since Last Earnings Report?
by Zacks Equity Research
P&G (PG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
This is Why Procter & Gamble (PG) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
The Zacks Analyst Blog Highlights: Nike, Dow, Procter & Gamble Company, 3M and Microsoft
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, Dow, Procter & Gamble Company, 3M and Microsoft
PepsiCo's (PEP) Micro-Fulfillment Center to Enhance Delivery
by Zacks Equity Research
PepsiCo (PEP) has launched a micro-fulfillment center in Illinois to stay ahead in the ongoing online race stemming from the coronavirus-led stay-at-home trend.
5 Blue-Chip Stocks to Buy on Coronavirus Vaccine Hope
by Nalak Das
A COVID-19 vaccine likely to benefit the Dow the most as it is more inclined toward cyclical stocks. Five among these are NIKE (NKE), Dow (DOW), The Procter & Gamble (PG), 3M (MMM) and Microsoft (MSFT).